The role of the cytokine network in the CNS and psychic disorders;Die Rolle des Zytokinnetzwerks im ZNS und psychische Storungen

Nervenarzt

Volumn 68, Issue 1, 1997, Pages 11-20

  Muller N ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

central nervous system; cytokines; neurotransmitter; psychiatric disorders; psychoneuroimmunology

Indexed keywords

CYTOKINE; NORADRENALIN;

DEPRESSION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; ILLNESS BEHAVIOR; REVIEW; SCHIZOPHRENIA; SLEEP;

BLOOD-BRAIN BARRIER; BRAIN DISEASES; CYTOKINES; DELIRIUM, DEMENTIA, AMNESTIC, COGNITIVE DISORDERS; DIAGNOSIS, DIFFERENTIAL; HUMANS; MENTAL DISORDERS; NEUROTRANSMITTER AGENTS; PSYCHONEUROIMMUNOLOGY;

EID: 0031051076     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001150050092     Document Type: Review

References (117)

1. Aisen PS, Davis KL (1994) Inflammatory mechanisms in Alzheimer's disease: implications for therapy. Am J Psychiatry 151:1105-1113
2. Akiyoshi M, Shimizu Y, Saito M (1990) Interieukin-1 increases norepinephrine turnover in the spleen and lung in rats. Biochem Biophys Res Commun 173: 1266-1270
3. Alonso R, Chaudieu I, Diorio J, Krishnamurthy A, Quirion R, Boksa P (1993) Interleukin-2 modulates evoked release of [3H]dopamine in rat cultured mesencephalic cells. J Neurochem 61: 1284-1290
4. Araujo DM, Lapchak PA, Chabot JG, Nair NP, Quirion R (1989) Characterization and possible role of growth factor and lymphokine receptors in the regulation of cholinergic function in the mammalian brain. Prog Clin Biol Res 317: 423-436
5. Araujo DM, Lapchak PA, Collier B, Quirion R (1989) Localization of interleukin-2 immunoreactivity and interleukin-2 receptors in the rat brain: interaction with the cholinergic system. Brain Res 498: 257-266
6. Awatsuji H, Furukawa Y, Nakajima M, Furukawa S, Hayashi K (1993) Interleukin-2 as a neurotrophic factor for supporting the survival of neurons cultured from various regions of fetal rat brain. J Neurosci Res 35: 305-311
7. Banks WA, Kastin AJ (1992) The interleukins-1 alpha, -1 beta, and -2 do not acutely disrupt the murine blood-brain barrier. Int J Immunopharmacol 14: 629-636
8. Banks WA, Kastin AJ, Gutierrez EG (1993) Interleukin-1 alpha in blood has direct access to cortical brain cells. Neurosci Lett 163: 41-44
9. Bartrop RW, Lazarus L, Luckhurst E, Kilch LG, Penny R (1977) Depressed lymphocyte function after bereavement. Lancet I: 834-336
10. Benveniste EN (1992) Inflammatory cytokines within the central nervous system: sources, function, and mechanism of action. Am J Physiol 263: C1-C16
11. Berkenbosch F, Van Oers J, Del Ray A, Tiders F, Besedovsky HO (1987) Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. Science 238: 524-526
12. Besedovsky HO, Del Ray A, Sorkin E, Dinarello CA (1986) Immunregulatory feedback between interleukin-1 and glucocorticoid hormones. Science 233: 652-654
13. Breder CD, Dinarello CA, Saber CB (1988) Interleukin-1 immunoreactive innervation of the human hypothalamus. Science 240: 321-324
14. Bresnihan H, Jasin HE (1977) Suppressor function of peripheral blood mononuclear cells in normal individuals and in patients with systemic lupus erythematosus. J Clin Invest 59: 106-116
15. Bruce LC, Peebles AMS (1903) Clinical and experimental observations on catatonia. J Ment Sci 49: 614-628
16. Cacabelos R, Alvarez XA, Franco-Ma-Side A, Fernández-Novoa L, Caamaño J (1994) Serum tumor necrosis factor (TNF) in Alzheimer's disease and multiinfarct dementia. Methods Find Exp Clin Pharmacol 16: 29-35
17. Cancilla PA, DeBault LE (1983) Neutral amino acid transport properties of cerebral endothelial cells in-vitro. J Neuropathol Exp Neurol 42: 191-199
18. Caruso C, Candore G, Cigna D, Colucci AT, Modica MA (1993) Biological significance of soluble IL-2 receptor. Med Inflamm 2: 3-21
19. Dameshek W (1930) White blood cells in dementia praecox and dementia paralytica. Arch Neurol Psychiatry 24: 855
20. DeLisi LE, Goodman S, Neckers LM, Wyatt RJ (1982) An analysis of lymphocyte subpopulations in schizophrenic patients. Biol Psychiatry 17: 1003-1009
21. De Souza EB (1994) Identification, localisation and modulation of interleukin-1 receptors in the central nervous system. Neuropsychopharmacology 10: 830S
22. Denicoff KD, Rubinoff DR, Papa MZ, Simpson C, Seipp CA, Lotze MT, Chang AE, Rosenstein D, Rosenberg SA (1987) The neuropsychiatrie effects of treatment with interleukin-2 and lymphokine-activated killer cells. Ann Intern Med 107: 293-300
23. Dunn AJ (1992) Endotoxin-induced activation of cerebral catecholamine and serotonin metabolism: comparison with interleukin-1. J Pharmacol Exp Ther 261: 964-969
24. Dunn AJ (1994) Pituitary-adrenal activation and behavioral activity of interleukin-1. Neuropsychopharmacology 10: 833S
25. Fernstrom JD, Faller DV (1977) Neutral amino acids in the brain: changes in response to food ingestion. J Neurochem 30: 1511-1538
26. Fessel WJ (1963) The antibrain factors in psychiatric patients' sera. Arch Gen Psychiatry 8: 614-621
27. Frei K, Malipiero UV, Leist TP, Zinkernagel RM, Schwab ME, Fontana A (1989) On the cellular source and function of interleukin 6 produced in the central nervous system in viral diseases. Eur J Immunol 19: 689-694
28. Frenzel KH, Müller N, Heidmann D, Hampel H, Kretzschmar HA, Penning R, Ackenheil M (1995) Expression of T cell receptor gd antigens in human brain tissue. Neuroimmunomodulation 2: 115-120
29. Funke I, Hahn A, Rieber EP, Weiss E, Riethmüller G (1987) The cellular receptor (CD4) of the human deficiency virus is expressed on neurons and glia cells in human brain. J Exp Med 165: 1230-1235
30. Ganguli R, Rabin BS, Kelly RH, Lyte M, Ragu U (1987) Clinical and laboratory evidence of autoimmunity in acute schizophrenia. In: Jancoviv BD. Marcovic BM, Spector NH (eds) Neuroimmune interactions. Ann NY Acad Sci 496: 676-685
31. Ganguli R, Rabin BS (1989) Increased serum interleukin 2 recpetor levels of soluble interleukin-2 receptors in schizophrenia. Arch Gen Psychiatry 46: 291-292
32. Ganguli R, Rabin BS, Belle SH (1989) Decreased interleukin-2 production in schizophrenic patients. Biol Psychiatry 26: 427-430
33. Ganguli R, Yang Z, Shurin G, Chengappa R, Brar JS, Gubbi AV, Rabin BS (1994) Serum interleukin-6 concentration in schizophrenia: elevation associated with duration of illness. Psychiatry Res 51: 1-10
34. Gattaz WF, Dalgalarrado P, Schröder HC (1992) Abnormalities in serum concentrations of interleukin-2, inferon α and interferon γ in schizophrenia not detected. Schizophr Res 6: 237-241
35. Glaser R, Kiecolt-Glaser JK, George JM, Speicher CE, Holliday JE (1985) Stress, loneliness and change in herpes virus latency. J Behav Med 8: 249-260
36. Glass JD, Wesselingh SL, Selnes OA, McArthur JC (1993) Clinical-neuropathologic correlation in HIV-associated dementia. Neurology 43: 2230-2237
37. Gutierrez EG, Banks WA, Kastin AJ (1993) Murine tumor necrosis factor alpha is tranported from blood to brain in the mouse. J Neuroimmunol 47: 169-176
38. Hama T, Kushima Y, Miyamoto M, Kubota M, Takei N, Hatanaka H (1991) Interieukin-6 improves the survival of mesencephalic catochelaminergic and septal cholinergic neurons from patnatal, two-week-old rats in cultures. Neuroscience 40: 445-452
39. Hashimoto M, Ishikawa Y, Yokota S, Goto F, Bando T, Sakakibara Y, Iriki M (1991) Action side of circulating interleukin-1 on the rabbit brain. Brain Res 540: 217-223
40. Heath RG, Krupp IM (1967) Schizophrenia as an immunologic disorder. I. Demonstration of antibrain globulins by fluorescent antibody techniques. Arch Gen Pschiatry 39: 82-87
41. Henneberg A, Riedl B, Dumke HO, Kornhuber HH (1990) T-lymphocyte subpopulations in schizophrenic patients. Eur Arch Psychiatry Clin Neurosci 239: 283-284
42. Hodgsen HJF, Wand IR, Isselbacher KJ (1978) Alteration in suppressor cell activity in chronic active hepatitis. Proc Natl Acad Sci USA 75: 1549-1553
43. Hornberg M, Arolt V, Wilke I, Kruse A, Kirchner H (1995) Production of interferons and lymphokines in leukocyte cultures of patients with schizophrenia. Schizophr Res 15: 237-242
44. Joyce PR, Hawes CR, Mulder RT, Sellman JD, Wilson DA, Boswell DR (1992) Elevated levels of acute phase plasma proteins in major depression. Biol Psychiatry 32: 713-718
45. Kent S, Bluthe R-M, Kelley KW, Dantzer R (1992) Sickness behavior and drug development. TIPS 13: 24-28
46. Kiecolt-Glaser JK, Glaser R (1987) Psychosocial influences on herpes virus latency. In: Kurstak E, Lipowski ZJ, Morzov PV (eds) Viruses, immunity, and mental disorders. Plenum Press, New York
47. Kirch DG, Kaufmann CA. Papadopoulos NM, Martin B, Weinberger DR (1985) Abnormal cerebrospinal fluid protein indices in schizophrenia. Biol Psychiatry 20: 1039-1046
48. Knight JG (1982) Dopamine-receptor-stimulating autoantibodies, a possible cause of schizophrenia. Lancet I: 1073-1076
49. Knight JG, Knight A, Pert CB (1987) Is schizophrenia a virally triggered autoimmune disease? In: Helmchen H, Henn FA (eds) Biological perspectives of schizophrenia. Wiley, New York, pp 107-127
50. Krüger KW (1984) Lupus erythematodes und Zentralnervensystem. Nervenarzt 55: 165-172
51. Kurtz G, Müller N (1994) The antiphospholipid syndrome and psychosis. Am J Psychiatry 151: 1841-1842
52. Lapchak PA (1992) A role for interleukin-2 in the regulation of striatal dopaminergic function. Neuroreport 3: 165-168
53. Laudenslager ML (1987) Psychosocial stress and susceptibility to infections disease. In: Kurstak E, Lipowski ZJ, Morozov PV (eds) Viruses, immunity, and mental disorders. Plenum Press, New York
54. Lechan RM, Toni R, Clark BD, Cannon JG, Shaw AR, Dinarello CA, Reichlin S (1990) Immunoreactive interleukin-1 beta localization in the rat forebrain. Brain Res 514: 135-140
55. Lehmann-Facius H (1939) Serologisch-analytische Versuche mit Liquores und Seren von Schizophrenen. Allg Z Psychiatrie 110: 232-243
56. Lewandowski G, Hobbs MV, Blomom FE (1994) Alteration of intracerebral cytokine production in mice infected with herpes simplex virus types 1 and 2. J Neuroimmunol 55: 23-34
57. Licinio J, Seibyl JP, Altemus M, Charney DS, Krystal JH (1993) Elevated levels of interleukin-2 inneuroleptic-free schizophrenics. Am J Psychiatry 150: 1408-1410
58. Licinio J, Wing M-L (1994) Lokalization of interleukin-1 and interleukin-1 mRNA in brain: pathophysiological implications. Neuropsychopharmacology 10: 834S
59. Lieberman AP, Pitha PM, Shin HS, Shin ML (1989) Production of tumor necrosis factor and other cytokines by astrocytes stimulatd with lipopolysaccharide or a neurotropic virus. Proc Natl Acad Sci USA 86: 6348-6352
60. Maes M, Bosmans E, Suy E, Vandervorst C, Dejonckheere C, Minner B, Raus J (1991) Depression-related disturbances in mitogen-induced lymphocyte responses, interleukin-1β, and soluble interleukin-2-receptor production. Acta Psychiatr Scand 84: 379-386
61. Maes M, Bosmans E, Suy E, Vandervorst C, Dejonckheere C, Raus J (1991) Antiphospholipid, anti-nuclear, Epstein-Barr and cytomegalovirus antibodies, and soluble interleukin-2 receptors in depressive patients. J Affect Disord 21: 133-140
62. Maes M, Scharpé S, Meltzer HY, Bosmans E, Suy E, Calabrese J, Cosyns P (1993) Relationships between lower plasma L-tryptophan levels and immune-inflammatory variables in depression. Psychiatry Res 49: 151-165
63. Maes M, Meltzer HY, Scharpé S, Bosmans E, Suy E, De Meester I, Calabrese J, Cosyns P (1993) Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression. Psychiatry Res 49: 11-27
64. Maes M, Meltzer HY, Bosmans E (1994) Immune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine. Acta Psychiatr Scand 89: 346-351
65. Maes M, Smith R, Scharpe S (1995) The monocyte-T-lymphocyte hypothesis of major depression. Psychoneuroendocrinology 20: 111-116
66. Maes M, Bosmans E, Meltzer HY (1995) Immunoendocrine aspects of major depression. Relationships between plasma interleukin-6 and soluble interleukin-2 receptor, prolactin and cortisol. Eur Arch Psychiatry Clin Neurosci 245: 172-178
67. Maes M (1995) Evidence for an immune response in major depression: a review and hypothesis. Prog Neuropsychopharmacol Biol Psychiatry 19: 11-38
68. McAllister CG, Rapaport MH, Pickar D, Podruchny TA, Christison G, Alphs LD, Paul SM (1989) Increased number of CD5+ B-lymphocytes in schizophrenic patients. Arch Gen Psychiatry 46: 890-894
69. McAllister CG, Kammen DP van, Rehn TJ, Miller AN, Gurklis J, Kelley ME, Yao J, Peters JL (1995) Increases in CSF levels of interleukin-2 in schizophrenia: effects of recurrance of psychosis and medication status. Am J Psychiatry 152: 1291-1297
70. Merill JE (1992) Tumor necrosis factor alpha, interleukin 1 and related cytokines in brain development: normal and pathological. Dev Neurosci 14: 1-10
71. Minami M, Kuraishi Y, Yamaguchi T, Nakai S, Hirai Y, Satoh M (1991) Immobilization stress induces interleukin-1 beta mRNA in the rat hypothalamus. Neurosci Lett 123: 254-256
72. Müller N, Ackenheil M, Eckstein R, Hofschuster E, Mempel W (1987) Reduced suppressor cell function in psychiatric patients. Ann NY Acad Sci 496: 686-690
73. Muller N, Ackenheil M, Hofschuster E, Mempel W, Eckstein R (1991) Cellular immunity in schizophrenic patients before and during neuroleptic therapy. Psychiatry Res 37: 147-160
74. Müller N, Gizycki-Nienhaus B, Günther W, Meurer M (1992) Depression as a possible cerebral manifestation of scleroderma: immunological findings in serum and CSF. Biol Psychiatry 31: 1151-1156
75. Müller N, Ackenheil M, Hofschuster E, Mempel W, Eckstein R (1993) Cellular immunity, HLA-class I antigens, and family history of psychiatric disorder in endogenous psychoses. Psychiatry Res 48: 201-217
76. Müller N, Ackenheil M, Hofschuster E, Mempel W, Eckstein R (1993) Investiations of the cellular immunity during depression and the free interval: evidence for an immune activation in affective psychosis. Prog Neuropsychopharmacol Biol Psychiatry 17: 713-730
77. Müller N, Ackenheil M (1995) The immune system and schizophrenia. In: Leonard BE, Miller K (eds) Stress, the immune system and psychiatry. Wiley, New York, pp 137-164
78. Müller N, Ackenheil M (1995) Immunoglobulin and albumin contents of cerebrospinal fluid in schizophrenic patients: the relationship to negative symptomatology. Schizophr Res 14: 223-228
79. Müller N (1995) Psychoneuroimmunologie psychiatrischer Erkrankungen. Untersuchungen bei Schizophrenie und affektiven Psychosen. Springer, Berlin Heidelberg New York
80. Müller N (1995) Psychoimmunology: Implications for the drug treatment of psychiatry disorders. CNS Drugs 4: 125-140
81. Muraguchi A, Hirano T, Tang B, Matsuda T, Horii Y, Nakajima K, Kishimoto T (1988) The essential role of B-cell stimulating factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells. J Exp Med 167: 332-344
82. Naber D, Einhäupl K, Strauß A, Fiedler S (1986) Klinische Bedeutung pathologischer Liquor-Befunde bei schizophrenen Patienten. Psycho 12: 364-365
83. Nässberger L, Träksman-Bendz L (1993) Increased soluble interleukin-2 receptor concentrations in suicide attempters. Acta Psychiatr Scand 88: 48-52
84. Nemni R, Iannaccone S, Quattrini A, Smirne S, Sessa M, Lodi M, Erminio C, Canal N (1992) Effect of chronic treatment with recombinant interleukin-2 on the central nervous system of adult and old mice. Brain Res 591: 248-252
85. Nisticò G, De Sarro G (1991) Is interleukin 2 a neuromodulator in the brain? TINS 14: 146-150
86. Norris JG, Benveniste EN (1993) Interleukin-6 production by astrocytes: induction by the aeurotransmitter norepinephrine. J Neuroimmunol 45: 137-146
87. Pandey RS, Gupta AK, Chaturvedi JC (1981) Autoimmune model of schizophrenia with special reference to antibrain antibodies. Biol Psychiatry 16: 1123-1136
88. Plata-Salaman CR (1991) Immunoregulators in the nervous system. Neurosci Biobehav Rev 15: 185-215
89. Plata-Salaman CR, Ffrench-Mullen JM (1993) Interleukin-2 modulates calcium currents in dissociated hippocampal CA1 neurons. Neuroreport 4: 579-581
90. Rabin BS, Ganguli R, Cunnick JE, Lysle DT (1988) The central nervous system - immune system relationship. Clin Lab Med 8: 253-268
91. Rada P, Mark GP, Vitek MP (1991) Interleukin-1 beta decreases acetylcholine measured by microdialysis in the hippocampus of freely moving rats. Brain Res 15: 287-290
92. Rapaport MH, McAllister CG, Pickar D, Nelson DM, Paul SM (1989) Elevated levels of soluble interleukin 2 receptors in schizophrenia. Arch Gen Psychiatry 46: 291-292
93. Rapaport MH, Torrey EF, McAllister CG, Nelson DM, Pickar D, Paul SM (1993) Increased serum soluble interleukm-2 receptors in schizophrenic monozygotic twins. Eur Arch Psychiatry Clin Neurosci 243: 7-10
94. Rapaport MH, McAllister CG, Kim YS, Han JH, Pickar D, Nelson DM, Kirch DG. Paul SM (1994) Increased soluble interleukin-2 receptors in Caucasian and korean schizophrenic patients. Biol Psychiatry 35: 767-771
95. Raps A, Abramovich Y, Assael M et al. (1986) Relation between schizophrenic-like psychosis and Sjögren-syndrome (SS). Isr J Psychiatry Relat Sci 23: 321-324
96. Reichlin S (1993) Neuroendokrine-immune interactions. N Engl J Med 329: 1246-1253
97. Sawada M, Suzumura A, Marunouchi T (1992) TNF-alpha induces IL-6 production by astrocytes, but not by microglia. Brain Res 583: 296-299
98. Schleuning M, Brumme V, Wilmanns W (1994) Inhibition of cyclosporin A/FK 506 resistant, lymphokine-induced T-cell activation by phenothiazine derivates. Naunyn Schmiedebergs Arch Pharmacol 350: 100-103
99. Shimojo M, Imay Y, Nakajiama K, Mizushima S, Uemura A, Kohsaka A (1993) Interleukin enhances the viability of primary cultured rat neocortical neurons. Neurosci Lett 151: 170-173
100. Shintani F, Kanba S, Nakaki T, Nibuya M, Kinoshita N, Suzuki E, Yagi G, Kato R, Asai M (1993) Interleukin-1 beta augments release of norepinephrine, dopamine, and serotonin in the rat anterior hypothalamus. J Neurosci 13: 3574-3581
101. Smith RS (1991) Is schizophrenia caused by excessive production of interleukin-2 and interleukin-2 receptors by gastrointestinal lymphocytes? Med Hypotheses 34: 225-229
102. Smith RS (1992) A comprehensive macrophage-T-lymphocyte theory of schizophrenia. Medical Hypotheses 39: 248-257
103. Soliven B, Albert J (1992) Tumor necrosis factor modulates the inactivation of catecholamine secretion in cultured sympathetic neurons. J Neurochem 58: 1073-1078
104. Solomon GF (1981) Emotional and personality factors in the onset and course of autoimmune disease, particularly rheumatoid arthritis. In: Ader R (ed) Psychoneuroimmunology. Academic Press, New York London, pp 159-182
105. Song C, Leonard BE (1994) An acute phase protein response in the olfactory bulbectomised rat: effect of sertraline treatment. Med Sci Res 22: 313-314
106. Spangelo BL, Judd AM, Isakson PC, MacLeod RM (1989) Interleukin-6 stimulates anterior pituitary hormone release in-vitro. Endocrinol Metab Clin North Am 125: 575-577
107. Sperner-Unterweger B, Barnas C, Fuchs D, Kemmler G, Wachter H, Hinterhuber H, Fleischhacker WW (1992) Neopterin production in acute schizophrenic patients: an indicator of alterations of cell mediated immunity. Psychiatry Res 42: 121-128
108. Sundar SK, Cierpial MA, Kilts C, Ritchie JC, Weiss M (1990) Brain IL-1 induced immunosuppression occurs through activation of both pituitary-adrenal axis and sympathetic nervous system by corticotropin-releasing factor. J Neurosci 10: 3701-3706
109. Syvalathi E, Eskola J, Runskanen O, Laine T (1985) Nonsuppression of cortisol in depression and immune function. Prog Neuropsychopharmacol Biol Psychiatr 9: 413-422
110. Tyor WR, Glass JD, Griffin JW, Becker PS, McArthur JC, Bezman L, Griffin DE (1992) Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann Neurol 31: 349-360
111. Villemain F, Chatenoud L, Galinowski A, Homo-Delarche F, Genestet D, Loo H, Zarifarain E, Bach JF (1989) Aberrant T-cell-mediated immunity in untreated schizophrenic patients: deficient interleukin-2 production. Am J Psychiatry 146: 609-616
112. Waltrip II RW, Carrigan DR, Carpenter WT Jr (1990) Immunopathology and viral reactivation. A general theory of schizophrenia. J Nerv Ment Dis 178: 729-738
113. Weiss JM, Quan N, Sundar SK (1994) Immunological consequences of interleukin-1 in the brain. Neuropsychopharmacology 10: 833S
114. Yolken RH, Torrey EF (1995) Viruses, schizophrenia, and bipolar disorder. Clin Microbiol Rev 8: 131-145
115. Zalcman S, Green-Johnson JM, Murray J, Nance DM, Dyck D, Anisman H, Greenberg AH (1994) Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6, Brain Res 643: 40-49
116. Zisook S, Shuchter SR, Irwin M, Darko DF, Sledge P, Resovsky K (1994) Bereavment, depression, and immune function. Psychiatry Res 52: 1-10
117. Zubin J, Spring B (1977) Vulnerability - a new view of schizophrenia. J Abnorm Psychol 86: 103-126